[1] Eddens T, Kolls JK. Pathological and protective immunity to Pneumocystis infection[J]. Semin Immunopathol, 2015,37(2):153-162. [2] Huang Y, Yang J, Lee N, et al. Treatment of Pneumocystis jirovecii pneumonia in HIV-infected patients:a review[J]. Expert Rev Anti Infect Ther, 2017,15(9):873-892. [3] Shibata S, Kikuchi T. Pneumocystis pneumonia in HIV-1-infected patients.[J]. Respir Investig, 2019,57(3):213-219. [4] Calderón EJ, Gutiérrez-Rivero S, Durand-Joly I, et al. Pneumocystis infection in humans:diagnosis and treatment[J]. Expert Rev Anti Infective Ther, 2010,8(6):683-701. [5] Roux A, Canet E, Valade S, et al. Pneumocystis jirovecii pneumonia in patients with or without AIDS, France[J]. Emerg Infect Dis, 2014,20(9):1490-1497. [6] 中华医学会感染病学分会艾滋病丙型肝炎学组, 中国疾病预防控制中心. 中国艾滋病诊疗指南(2018版)[J]. 中华临床感染病杂志, 2018,11(6):411-432. [7] Huang L, Cattamanchi A, Davis JL, et al. HIV-associated Pneumocystis pneumonia[J]. Proc Am Thorac Soc, 2011,8(3):294-300. [8] Blaas S. Pneumocystis jirovecii pneumonia in patients with autoimmune diseases[J]. Z Rheumatol, 2017,76(9):761-766. [9] White PL, Backx M, Barnes RA. Diagnosis and management of Pneumocystis jirovecii infection[J]. Expert Rev Anti Infect Ther, 2017,15(5):435-447. [10] Turner D, Schwarz Y, Yust I. Induced sputum for diagnosing Pneumocystis carinii pneumonia in HIV patients:new data, new issues[J]. Eur Respir J, 2003,21(2):204-208. [11] Guo F, Chen Y, Yang SL, et al. Pneumocystis pneumonia in HIV-infected and immunocompromised non-HIV infected patients:a retrospective study of two centers in China[J]. Plos One, 2014,9(7):e101943. [12] Roblot F, Godet C, Moal GL, et al. Analysis of underlying diseases and prognosis factors associated with Pneumocystis carinii pneumonia in immunocompromised HIV-negative patients[J]. Eur J Clin Microbiol Infect Dis, 2002,21(7):523-531. [13] CDC, IDSO. Guidelines for preventing opportunistic infections among hematopoietic stem cell transplant recipients[J]. Cytotherapy, 2001,3(1):41-54. [14] Kaplan JE, Benson C, Holmes K, et al. Guidelines for prevention and treatment of opportunistic infections in HIV-infected adults and adolescents.[J]. MMWR Recomm Rep, 2009,58(RR-4):1-207. [15] Zaman MK, White DA. Serum lactate dehydrogenase levels and Pneumocystis carinii pneumonia:diagnostic and prognostic significance[J]. Am Rev Respir Dis, 1988,137(4):796-800 [16] 吴海涵, 梁林, 于农, 等. 血清乳酸脱氢酶在耶氏肺孢子虫肺炎诊断、治疗及预后评估中的价值[J]. 检验医学与临床, 2014(1):111-112. [17] Li WJ, Guo YL, Liu TJ, et al. Diagnosis of pneumocystis pneumonia using serum (1-3)-β-D-Glucan:a bivariate meta-analysis and systematic review.[J]. J Thorac Dis, 2015,7(12):2214. [18] Shimizu Y, Sunaga N, Dobashi K, et al. Serum markers in interstitial pneumonia with and without Pneumocystis jirovecii colonization:a prospective study[J]. BMC Infec Dis, 2009,9(1):47-52. [19] Tasaka S, Hasegawa N, Kobayashi S, et al. Serum indicators for the diagnosis of Pneumocystis pneumonia[J]. Chest, 2007,131(4):1173-1180. |